MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
Recruiting now · Not applicable
Conditions studied: Cutaneous T-Cell Lymphoma, Graft Vs Host Disease, Graft Rejection
In brief
The objective of this study is to describe the type of cell death induced by extracorporeal photochemotherapy, depending on the cell type, using a panel of complementary analysis techniques.
Key facts
- Study ID
- NCT05333367
- Run by
- Centre Hospitalier Universitaire de Besancon
- People needed
- 20
- Starts
- 2022-04-15
- Expected to finish
- 2025-07-01
- Last updated by the study team
- 2024-11-21
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients
- Treated with ECP for at least 1 month, for control of GVHD in hematopoietic cell allograft (acute or chronic GVHD), treatment and control of cellular or humoral rejection in solid organ transplantation (heart, lung, kidney) or in the treatment of cutaneous T-cell lymphoma
You may not qualify if…
- Subjects with limited legal capacity.
- Subjects judged by the investigator to be unlikely to comply with study procedures
- Subjects with no social security coverage.
- Pregnant women.
- Subjects still in the exclusion period of another study, or according to the national registry of clinical trial participants.
Where it is running
- Centre Hospitalier Universitaire de Besançon — Besançon, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.